A DNA-based biosensor for the fast and sensitive detection of contaminants in biological samples

# Record card
133
Thematic areas
Agrifood
Agrifood / Food quality & safety
Agrifood / Nutrition & health
Health & Biotech
Health & Biotech / Diagnostic kits
Health & Biotech / Biosensors
Description

A biosensor based on magnetic microspheres functionalized with a DNA-aptamer was developed for the specific biomonitoring of biological contaminants (mycotoxins) in urine.

The biosensor is used in a test tube into which the diluted urine sample is added. The biosensor has been validated for the monitoring of ochratoxin (OTA) with high sensitivity and selectivity thanks to the presence of a DNA sequence (aptamer), specifically designed to capture traces of the analyte (up to 10-12 ng/mL of OTA), and to a DNA-based system specifically designed to hyper-amplify the detection signal, in 4 hours, and at a constant temperature of 30 °C.

The OTA is concentrated in the sample and its presence displayed as a blue tint in the solution. It does not require special equipment other than pipettes and a small portable incubator. The biosensor can also be used for quantitative analysis using a portable photometer, with recoveries greater than 95%, high specificity and precision.

The biosensor is being validated for the analysis of other contaminants in food matrices or biological samples.

Business fields
Agrifood
Industry
Type of innovation
Product / process innovation in integration with an already existing technology
Description of innovative features / Competitive advantages

Mycotoxins are biological contaminants of food and feed commonly analysed by chromatographic techniques that require expensive and cumbersome equipment and skilled operators. The biosensor, on the other hand, represents a valid alternative thanks to its high portability and ease of use, as well as a reduction in costs and analysis times. We have shown that the results obtained with the biosensor are comparable to those obtained with the standard chromatographic methods. Another strength of the biosensor is the ability to concentrate the analyte in the sample, thereby increasing sensitivity. The biosensor does not require any purification of the urine sample, thus speeding up the analysis time. The portability of the biosensor allows its use on site, facilitating monitoring studies, and allowing the implementation of contamination containment measures in a short time. Due to the plasticity and high versatility of the biosensor structure, it can be used for the detection of other contaminants such as pesticides, viruses, drugs, etc., in a simple way, by modifying only one component of the biosensor. It differs from other diagnostic systems for its high sensitivity and applicability in complex matrices such as urine samples.

Reference market
Incremental innovation
Impacts on existing markets
Development stage
Feasibility
TRL
4
Advantages
Product/process/service/technology optimization
Cost reduction
Patentable technology
No
Patented technology
No
Publication of technology
Published
Technology validation/demonstration
Internal validation
Market positioning
Italian
European
International
Partner required
Enteprise
Cooperation in national /european / international project

Information
For more information and/or to be put in contact with the Research Team, please contact the Project Manager:

Barbara Angelini - Project Manager
CNR - Unità Valorizzazione della Ricerca
Phone number 06.49932415
E-mail barbara.angelini@cnr.it